Suchergebnisse - "Advanced breast cancer"

PubPharm (3.890)

1

Preventing alpelisib-related hyperglycaemia in HR+/HER2-/PIK3CA-mutated advanced breast cancer using metformin (METALLICA) : a multicentre, open-label, single-arm, phase 2 trial

enthalten in: EClinicalMedicine | 2024

von Llombart-Cussac, A. | Pérez-Garcia, J. | Ruiz Borrego, M. | +25

2

Real-world progression-free survival and overall survival of palbociclib plus endocrine therapy (ET) in Japanese patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer in the first-line or second-line setting : an observational study

enthalten in: Breast cancer (Tokyo, Japan) | 2024

von Yoshinami, T. | Nagai, S. | Hattori, M. | +17

3

ABC7 Consensus : Assessment by a German Group of Experts

enthalten in: Breast care (Basel, Switzerland) | 2024

von Ditsch, N. | Untch, M. | Fasching, P. | +12

4

Efficacy and safety of trastuzumab deruxtecan in treating human epidermal growth factor receptor 2-low/positive advanced breast cancer:A meta-analysis of randomized controlled trials

enthalten in: Critical reviews in oncology/hematology | 2024

von Ma, R. | Shi, Y. | Yan, R. | +3

5

Cost-effectiveness comparison of dalpiciclib and abemaciclib combined with an aromatase inhibitor as first-line treatment for HR+/HER2- advanced breast cancer

enthalten in: Expert review of pharmacoeconomics & outcomes research | 2024

von Hong, J. | Chen, T. | Ouyang, L. | +6

6

Apatinib beyond first progression is associated with prolonged overall survival in patients with advanced breast cancer : Results from an observational study

enthalten in: Experimental and therapeutic medicine | 2024

von Wang, J. | Jia, J. | Liu, J. | +2

7

Phase II randomized trial comparing metronomic anthracycline-containing chemotherapy versus standard schedule in untreated HER2 negative advanced breast cancer : activity and quality of life results of the GOIM 21003 trial

enthalten in: Breast (Edinburgh, Scotland) | 2024

von Orlando, L. | Maiello, E. | Orditura, M. | +17

8

Oral SERDs alone or in combination with CDK 4/6 inhibitors in breast cancer : Current perspectives and clinical trials

enthalten in: Breast (Edinburgh, Scotland) | 2024

von Apostolidou, K. | Zografos, E. | Papatheodoridi, M. | +3

9

First-line therapy with palbociclib in patients with advanced HR+/HER2- breast cancer : The real-life study PALBOSPAIN

enthalten in: Breast cancer research and treatment | 2024

von Martínez-Jañez, N. | Ezquerra, M. | Manso Sanchez, L. | +17

10

Variant allele frequency in circulating tumor DNA correlated with tumor disease burden and predicted outcomes in patients with advanced breast cancer

enthalten in: Breast cancer research and treatment | 2024

von Zhong, J. | Jiang, H. | Liu, X. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[389]